Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.
A Dagrosa, M Carpano, M Perona, L Thomasz, S Nievas, R Cabrini, G Juvenal, M Pisarev
Index: Appl. Radiat. Isot. 69(12) , 1752-5, (2011)
Full Text: HTML
Abstract
The aim of these studies was to evaluate the possibility of treating differentiated thyroid cancer by BNCT. These carcinomas are well controlled with surgery followed by therapy with (131)I; however, some patients do not respond to this treatment. BPA uptake was analyzed both in vitro and in nude mice implanted with cell lines of differentiated thyroid carcinoma. The boron intracellular concentration in the different cell lines and the biodistribution studies showed the selectivity of the BPA uptake by this kind of tumor.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
 |
4-Borono-L-phenylalanine
CAS:76410-58-7 |
C9H12BNO4 |
|
Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ult...
2014-04-01 [J. Nucl. Med. 55(4) , 616-21, (2014)] |
|
Low dose of gamma irradiation enhanced boronophenylalanine u...
2011-12-01 [Appl. Radiat. Isot. 69(12) , 1728-31, (2011)] |
|
Boron neutron capture therapy induces apoptosis of glioma ce...
2010-01-01 [BMC Cancer 10 , 661, (2010)] |
|
Boron neutron capture therapy for clear cell sarcoma (CCS): ...
2011-12-01 [Appl. Radiat. Isot. 69(12) , 1721-4, (2011)] |
|
EORTC trial 11001: distribution of two 10B-compounds in pati...
2009-08-01 [J. Cell. Mol. Med. 13(8B) , 1653-65, (2009)] |